Chung-Ang University
↗Seoul, South Korea
Chung-Ang University (CAU) is a premier private research university in South Korea, recognized for its leadership in the pharmaceutical, biotechnological, and medical sectors. It has been sponsored by the Doosan Group since 2008, which has significantly bolstered its research infrastructure and clinical capabilities. The university operates one of the oldest and most prestigious Colleges of Pharmacy in South Korea, consistently ranking as a top institution for pharmaceutical research funding and talent production.
The university is a hub for innovation through its Industry-Academic Cooperation Foundation (IACF), which manages extensive patent portfolios and technology transfers to major pharmaceutical companies. CAU is particularly strong in oncology, cardiovascular disease, and drug delivery systems, frequently collaborating with the Korea Drug Development Fund (KDDF) and the Ministry of Food and Drug Safety (MFDS) on regulatory science and new drug development projects.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Academic Research & Clinical Development
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$100M-$500M
Founded:1916
Ownership:nonprofit
Status:operating
FUNDING
Total Raised:$140M+
Investors:Ministry of Education (Korea), National Research Foundation of Korea, Doosan Group, Ministry of Science and ICT
PIPELINE
Stage:Phase 3
Lead Drug Stage:Phase 3
Modalities:Small molecule, RNA fragments, Natural extracts, Microneedles, Nanotechnology
Active Trials:45
Trial Phases:Phase 1: 12 | Phase 2: 18 | Phase 3: 15 | Phase 4: 5
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Doosan Group (Sponsor/Foundation)
Subsidiaries:Chung-Ang University Hospital, Chung-Ang University Gwangmyeong Hospital, CAU Technology Holding Company
Key Partnerships:Myungmoon Pharm (Digestive infection treatment), Philips Korea (Smart ECG Big Data/AI), KT (Smart Hospital Infrastructure), KDDF (New drug development consortium)
COMPETITION
Position:Leader
Competitors:Seoul National University, Yonsei University, Sungkyunkwan University, Hanyang University
LEADERSHIP
Key Executives:
Sang-Gue Park - President
Hong Chang-kwun - Chairman & CEO of CAU Healthcare System
Scientific Founders:Professor Kangseok Lee (Life Science/RNA research), Professor Sangkil Lee (Pharmacy/Alzheimer's drug formulation)
Board Members:Park Yong-sung (Former Chairman, Doosan Group)
LINKS
Website:cau.ac.kr
LinkedIn:LinkedIn Profile
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Chung-Ang University and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Chung-Ang University. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.